Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.4.1.2 (
acetyl-CoA carboxylase
)
2,876
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The cellular content of
acetyl-CoA carboxylase
[
acetyl-CoA:carbon-dioxide ligase
(
ADP-forming
),
EC 6.4.1.2
] in Saccharomyces cerevisiae is reduced by the addition of long-chain fatty acids to the culture medium. Mutant strains of S. cerevisiae defective in acyl-CoA synthetase [acid:CoA ligase (AMP-forming), EC 6.2.1.3] were isolated and used to determine whether fatty acid itself or a metabolite of fatty acid is more directly responsible for the repression of
acetyl-CoA carboxylase
. Cells of the mutant strains were capable of incorporating fatty acid to an extent comparable to that observed with the wild-type strain, but they accumulated markedly more of the incorporated fatty acid in the nonesterified form than did the wild-type cells. The level of
acetyl-CoA carboxylase
activity in the mutants, in contrast to that in the wild-type strain, was hardly affected by the addition of fatty acids to the medium. These results indicate that the activation of exogenous fatty acid is required for the repression of
acetyl-CoA carboxylase
, supporting the view that the repressive effect is mediated by some compound metabolically derived from fatty acid.
...
PMID:Evidence that acyl coenzyme A synthetase activity is required for repression of yeast acetyl coenzyme A carboxylase by exogenous fatty acids. 0 54
Specific polysomes involved the the synthesis of
acetyl-CoA carboxylase
[acetyl-CoA: carbon-dioxide ligase (
ADP-forming
),
EC 6.4.1.2
] have been identified by the binding of 125I-labeled antiacetyl-CoA carboxylase to rat liver polysomes. The binding is highly specific and occurs through the recognition of the nascent peptide chains on polysomes. With the use of the 125I-labeled antibody binding technique, it has been demonstrated that the relative content of
acetyl-CoA carboxylase
-synthesizing polysomes in the liver correlates well with the rate of hepatic synthesis of the enzyme in rats subjected to different dietary conditions as well as in alloxan-diabetic rats with or without insulin treatment.
...
PMID:Dietary and hormonal regulation of the content of acetyl coenzyme A carboxylase-synthesizing polysomes in rat liver. 0 84
Mutant strains of Candida lipolytica defective in acyl-CoA synthetase II [acid:CoA ligase (AMP-forming), EC 6.2.1.3] have been isolated. The mutants fail to grow on fatty acid as a sole carbon source but are capable of incorporating exogenous fatty acid into cellular lipids. This observation, together with our previous finding that mutant strains defective in acyl-CoA synthetase I cannot incorporate exogenous fatty acid into cellular lipids but are able to degrade fatty acid via beta-oxidation, indicates the presence of two functionally distinct long-chain acyl-CoA pools in the cell--i.e., one for lipid synthesis and the other for beta-oxidation. Unlike the wild-type and the revertant strains as well as the mutants lacking acyl-CoA synthetase II, the mutants defective in acyl-CoA synthetase I do not exhibit the repression of
acetyl-CoA carboxylase
[
acetyl-CoA:carbon-dioxide ligase
(
ADP-forming
),
EC 6.4.1.2
] by exogenous fatty acid. Measurement of the two long-chain acyl-CoA pools with the aid of appropriate mutant strains has indicated that the long-chain acyl-CoA to be utilized for lipid synthesis, but not that to be degraded via beta-oxidation, is involved in the repression of
acetyl-CoA carboxylase
.
...
PMID:Involvement of long-chain acyl coenzyme A for lipid synthesis in repression of acetyl-coenzyme A carboxylase in Candida lipolytica. 4 Dec 42
Labeling experiments with chicken liver cell monolayers and suspensions show that glucagon and N6, O2-dibutyryladenosine 3':5'-cyclic monophosphate (dibutyryl cyclic AMP) block fatty acid synthesis from acetate without appreciably affecting cholesterogenesis from acetate or acylglyceride synthesis from palmitate. Neither
acetyl-CoA carboxylase
[
acetyl-CoA:carbon-dioxide ligase
(
ADP-forming
),
EC 6.4.1.2
] activity assayed in the presence of citrate nor fatty acid synthetase activity is decreased in extracts of cells treated with glucagon. However, the cytoplasmic concentration of citrate, a required allosteric activator of
acetyl-CoA carboxylase
, is depressed more than 90% by glucagon or dibutyrl cyclic AMP. Pyruvate or lactate largely prevents the inhibitory action of these effectors on fatty acid synthesis by causing a large increase in cytoplasmic citrate level. Thus, it appears that glucagon, acting via cyclic AMP, inhibits fatty acid synthesis by blocking the formation of citrate, an essential activator of
acetyl-CoA carboxylase
.
...
PMID:Mechanism for acute control of fatty acid synthesis by glucagon and 3':5'-cyclic AMP in the liver cell. 19 2
Biotin carboxylase [biotin-carboxyl-carrier-protein:carbon-dioxide ligase (
ADP-forming
), EC 6.3.4.14] is the enzyme mediating the first step of the
acetyl-CoA carboxylase
[
acetyl-CoA:carbon-dioxide ligase
(
ADP-forming
),
EC 6.4.1.2
] reaction. We screened an Escherichia coli DNA library and a DNA fragment carrying the biotin carboxylase gene fabG, and its flanking regions were cloned. The gene for biotin carboxyl carrier protein was found 13 base pairs upstream of the fabG gene. Nucleotide sequencing of the recombinant plasmids revealed that the fabG codes for a 449-amino acid residue protein with a calculated molecular weight of 49,320, a value in good agreement with that of 51,000 determined by SDS/polyacrylamide gel electrophoresis of the purified enzyme. The deduced amino acid sequence of biotin carboxylase is also consistent with the partial amino acid sequence determined by Edman degradation. The primary structure of this enzyme exhibits a high homology with those of other biotin-dependent enzymes and carbamoyl-phosphate synthetase [carbon-dioxide:L-glutamine amino-ligase (
ADP-forming
, carbamate-phosphorylating), EC 6.3.5.5]; therefore, all these enzymes probably function through the same mechanism of reaction.
...
PMID:Acetyl-CoA carboxylase from Escherichia coli: gene organization and nucleotide sequence of the biotin carboxylase subunit. 168 20
Enzymically inactive
acetyl-CoA carboxylase
[
acetyl-CoA:carbon-dioxide ligase
(
ADP-forming
),
EC 6.4.1.2
] was found as a component of bovine milk-fat-globule membrane (MFGM).
Acetyl-CoA carboxylase
was present in MFGM at a higher concentration than in cytosolic or mitochondrial fractions of bovine mammary tissue, which makes it unlikely that its presence was due to simple contamination by these subcellular constituents.
...
PMID:Bovine milk-fat-globule membrane contains an enzymically inactive form of acetyl-CoA carboxylase. 256 77
Acetyl-CoA carboxylase
[acetyl-CoA:carbondioxide ligase (
ADP-forming
),
EC 6.4.1.2
] is the rate-limiting enzyme in the biogenesis of long-chain fatty acids. We have previously characterized five
acetyl-CoA carboxylase
mRNA species that differ in their 5' untranslated regions but not in the coding region. We have now characterized the exon-intron structure of the genomic DNA that encodes the 5' untranslated region of the mRNA. Generation of different forms of the mRNA is the result of the selective use of two promoters and differential splicing of five different exons. These five exons contain a total of 645 nucleotides and they are scattered over a 50-kilobase-pair genomic DNA region that we have characterized.
...
PMID:Structural features of the acetyl-CoA carboxylase gene: mechanisms for the generation of mRNAs with 5' end heterogeneity. 256 99
The mechanism underlying the ability of insulin to acutely activate
acetyl-CoA carboxylase
[acetyl-CoA: carbon-dioxide ligase (
ADP-forming
),
EC 6.4.1.2
; AcCoA-Case] has been examined in Fao Reuber hepatoma cells. Insulin promotes the rapid activation of AcCoACase, as measured in cell lysates, and this stimulation persists to the same degree after isolation of AcCoACase by avidin-Sepharose chromatography. The insulin-stimulated enzyme, as compared with control enzyme, exhibits an increase in both citrate-independent and -dependent activity and a decrease in the Ka for citrate. Direct examination of the phosphorylation state of isolated 32P-labeled AcCoACase after insulin exposure reveals a marked decrease in total enzyme phosphorylation coincident with activation. The dephosphorylation due to insulin appears to be restricted to the phosphorylation sites previously shown to regulate AcCoACase activity. All of these effects of insulin are mimicked by a low molecular weight autocrine factor, tentatively identified as an oligosaccharide, present in conditioned medium of hepatoma cells. These data suggest that insulin may activate AcCoACase by inhibiting the activity of protein kinase(s) or stimulating the activity of protein phosphatase(s) that control the phosphorylation state of the enzyme.
...
PMID:Insulin stimulates the dephosphorylation and activation of acetyl-CoA carboxylase. 289 91
Biotinyl proteins were labelled by incubation of SDS-denatured preparations of subcellular fractions of rat liver with [14C]methylavidin before polyacrylamide-gel electrophoresis. Fluorographic analysis showed that mitochondria contained two forms of
acetyl-CoA carboxylase
[acetyl-CoA:carbon dioxide ligase (
ADP-forming
)
EC 6.4.1.2
], both of which were precipitated by antibody to the enzyme. When both forms were considered, almost three-quarters of the total liver
acetyl-CoA carboxylase
was found in the mitochondrial fraction of liver from fed rats while only 3.5% was associated with the microsomal fraction. The remainder was present in cytosol, either as the intact active enzyme or as a degradation product. The actual specific activity of the cytosolic enzyme was approx. 2 units/mg of
acetyl-CoA carboxylase
protein while that of the mitochondrial enzyme was about 20-fold lower, indicating that mitochondrial
acetyl-CoA carboxylase
was relatively inactive. Fractionation of mitochondria with digitonin showed that
acetyl-CoA carboxylase
was associated with the outer mitochondrial membrane. The available evidence suggests that mitochondrial
acetyl-CoA carboxylase
represents a reservoir of enzyme which can be released and activated under lipogenic conditions.
...
PMID:Enzymatically inactive forms of acetyl-CoA carboxylase in rat liver mitochondria. 290 Dec 59
1.
Pyruvate carboxylase
(EC 6.4.1.1), purified from rat liver mitochondria to a specific activity of 14 units/mg, was used for the preparation of antibodies in rabbits. 2. Tissue distribution studies showed that pyruvate carboxylase was present in all rat tissues that were tested, with considerable activities both in gluconeogenic tissues such as liver and kidney and in tissues with high rates of lipogenesis such as white adipose tissue, brown adipose tissue, adrenal gland and lactating mammary gland. 3. Immunochemical titration experiments with the specific antibodies showed no differences between the inactivation of pyruvate carboxylase from mitochondrial or soluble fractions of liver, kidney, mammary gland, brown adipose tissue or white adipose tissue. 4. The antibodies were relatively less effective in reactions against pyruvate carboxylase from sheep liver than against the enzyme from rat tissues. 5.
Pyruvate carboxylase
antibodies did not inactivate either propionyl-CoA carboxylase or
acetyl-CoA carboxylase
from rat liver. 6. It is concluded that pyruvate carboxylase in lipogenic tissues is similar antigenically to the enzyme in gluconeogenic tissues and that the soluble activities of pyruvate carboxylase detected in many rat tissues do not represent discrete enzymes but are the result of mitochondrial damage during tissue homogenization.
...
PMID:Immunochemical studies with soluble and mitochondrial pyruvate carboxylase activities from rat tissues. 549 7
1
2
3
Next >>